ROSE (Risk Stratification of Syncope in the Emergency Department) Rule

ورودی‌های بالینی بیمار

پنل نتیجه و تصمیم بالینی
در انتظار ورودی‌ها
rose risk assessment
—risk level
آماده برای ارزیابی

پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.

طبقات خطر و بازه‌های امتیاز:
  • Low Risk0–0
  • High Risk1–7
Direct Clinical Answer

The ROSE (Risk Stratification of Syncope in the Emergency Department) Rule calculator is designed for bedside predicting 1-month serious outcome or death in patients presenting with syncope to the emergency department in clinical practice. The resulting score directly guides clinician decision-making regarding determining acute hospital.

Clinical Guidelines & Evidence

Predicts 1-month serious outcome or death in patients presenting with syncope to the emergency department. The ROSE rule identifies high-risk patients who require admission and further workup versus those who can be safely discharged. This validated clinical decision tool uses 7 readily available clinical variables to stratify syncope patients and reduce unnecessary admissions while identifying those at risk for serious cardiovascular outcomes.

Clinical Indication

The ROSE (Risk Stratification of Syncope in the Emergency Department) Rule is indicated for bedside clinical practice to support Predicts 1-month serious outcome or death in patients presenting with syncope to the emergency department. The ROSE rule identifies high-risk patients who require admission and further workup versus those who can be safely discharged. This validated clinical decision tool uses 7 readily available clinical variables to stratify syncope patients and reduce unnecessary admissions while identifying those at risk for serious cardiovascular outcomes.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.

Target Population

Target population comprises Adult and pediatric patients presenting with acute undifferentiated clinical complaints, trauma, or unstable vital signs. Clinical application is indicated across Emergency triage, acute resuscitation bays, observation units, and emergency trauma centers.

Limitations & Contraindications

Score calculations must never delay immediate life-saving airway stabilization, vascular access, or emergent surgical consult. Clinical exclusion: Q waves in lead III are specifically excluded due to positional artifacts.

Clinical Pearls & Action Plan

Adherence to core ABCDE resuscitation principles and bedside clinical gestalt must take absolute precedence over numerical decision tools. Guideline pearl: Original validation showed 87.2% sensitivity and 65.5% specificity.

Formula & Variables:

ROSE Rule = Presence of ANY of the following: (1) BNP ≥300 pg/ml OR (2) Bradycardia ≤50 bpm OR (3) Positive fecal occult blood OR (4) Hemoglobin ≤90 g/l OR (5) Chest pain with syncope OR (6) Q wave on ECG (not lead III) OR (7) Oxygen saturation ≤94%

Input Parameters

NameTypeRequiredDescription
bnp_levelstringYesB-type natriuretic peptide (BNP) level ≥300 pg/ml
bradycardiastringYesBradycardia ≤50 bpm in ED or pre-hospital
fecal_occult_bloodstringYesRectal examination showing fecal occult blood (if suspecting GI bleed)
anemiastringYesAnemia with hemoglobin ≤90 g/l (≤9.0 g/dl)
chest_painstringYesChest pain associated with syncope
q_wave_ecgstringYesECG showing Q wave (not in lead III)
oxygen_saturationstringYesOxygen saturation ≤94% on room air

Score Interpretation & Guidance

RangeStageDescription
0–0Low RiskNo ROSE criteria present
1–7High RiskOne or more ROSE criteria present

Evidence-Based References (EBM)

  • Reed MJ, Newby DE, Coull AJ, Prescott RJ, Jacques KG, Gray AJ. The ROSE (risk stratification of syncope in the emergency department) study. J Am Coll Cardiol. 2010 Feb 23;55(8):713-21. doi: 10.1016/j.jacc.2009.09.049.DOI: 10.1016/j.jacc.2009.09.049
  • Reed MJ, Mills NL, Weir CJ. Sensitive troponin assay predicts outcome in syncope. Emerg Med J. 2012 Dec;29(12):1001-3. doi: 10.1136/emermed-2011-200456.DOI: 10.1136/emermed-2011-200456
  • Colivicchi F, Ammirati F, Melina D, Guido V, Imperoli G, Santini M; OESIL (Osservatorio Epidemiologico sulla Sincope nel Lazio) Study Investigators. Development and prospective validation of a risk stratification system for patients with syncope in the emergency department: the OESIL risk score. Eur Heart J. 2003 May;24(9):811-9. doi: 10.1016/s0195-668x(02)00713-0.DOI: 10.1016/s0195-668x(02)00713-0

Related calculators